Actively Recruiting
Study of Blood Biomarkers for Detecting Mesenteric Ischemia in Patients with Mesenteric Artery Disease
Led by Belarusian State Medical University · Updated on 2026-09-23
120
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating blood biomarkers to improve early diagnosis of mesenteric ischemia MI, a serious condition related to vascular bowel disease that can be fatal if it progresses. This diagnostic study addresses the urgent need for reliable methods to identify MI and distinguish between non-transmural and transmural ischemia by validating combinations of biomarkers. The study involves collecting blood samples from patients suspected of having acute or chronic mesenteric artery diseases. Blood sampling is the only intervention, and it aims to detect markers that increase above reference levels within 24 hours after enrollment. Participants will provide blood samples and undergo clinical assessment at enrollment. The main outcome measured is the rise in MI biomarkers within one day. The study runs until 2026, and participants may be healthy volunteers or patients, with no treatment administered. Researchers focus on diagnostic accuracy and safety throughout the study period.
CONDITIONS
Brief Title
Mesenteric Ischemia Markers Study
Research Team
H
Hleb But-Husaim, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here